trial · primary record
Gemcitabine
Intrahepatic Cholangiocarcinoma (Icc)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 140 |
| Primary completion | 2030-07 |
| Primary endpoint | Overall Survival |
| Registry ID | NCT07691515 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:50.619Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07691515
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.